Analyst RatingAnalyst reiterates an Outperform rating for Elevance Health, Inc., indicating confidence in the company's future performance.
Price Target IncreasePrice target for Elevance Health, Inc. has been raised from $463 to $510, reflecting increased confidence in its future earnings potential.
Revenue GrowthCarelon Services revenue increased significantly, driven by mergers and acquisitions, with new behavioral and post-acute risk-based contracts highlighting business momentum.